<html>
<head>
    <meta name="GENERATOR" content="Microsoft Visual Studio 6.0">
    <title>Biological Use Authorization</title>
    <!-- <link rel="stylesheet" type="text/css" href="/appAsp/Include/ORA1.css"> -->
    <!-- <link rel="stylesheet" type="text/css" href="/appAsp/Include/Ora_BlueTables.css"> -->
    <link rel="stylesheet" type="text/css" href="/OrPortal/Forms/Compliance/IBC/IBC.css">
    <!-- Get Database Subroutines -->
    
    <!-- End Get Database Subroutines -->
    <!-- #XXXinclude virtual = "/appAsp/Include/StringUtilities.asp" -->
    
    <style>
.OriginalValuesBorder {
    border:3px solid orange;margin-top:5px;
}
.OriginalValuesTitle {
    color:orange;
    font-weight:bold;
}
.highlight {
    background-color:lightyellow; 
    border:1px solid orange;
    padding:2px;
}
.SemiHighlight {
    color:orange;
}
.warning {
    background-color:#FFE4C4; 
    border:1px solid orange;
    padding:2px;
}

th, .thBlue	{
	text-align:left;
	vertical-align:top;
	font-size:8pt;
	font-weight:bold;
	font-family:verdana;
}
td, .tdBlue	{
	text-align:left;
	vertical-align:top;
	font-size:8pt;
	font-family:verdana;
}

.THLine1 {
	color:navy;
	background:#F5F5F5;
	font-size:8pt;
	font-weight:bold;
}
.TDLine1 {
	color:navy;
	background:#F5F5F5;
	font-size:8pt;
}

.THLine2 {
	color:navy;
	background:white;
	font-size:8pt;
	font-weight:bold;
}
.TDLine2 {
	color:navy;
	background:white
	font-size:8pt;
}


.GlobalTd {
	background:white;
	color:navy;
	font-size:9pt;
}
.hdg1 {
	background:white;
	color:navy;
	font-size:12pt;
	font-weight:bold;
}
.xxxhdg2 {
	background:white;
	color:brown;
	font-size:11pt;
	font-weight:bold;
}
.hdg2 {
	background:navy;
	color:white;
	font-size:11pt;
	font-weight:bold;
	margin:1px;
	border-width:1px;
	border-color:white;
	padding:2px;
}
.hdg3 {
	background:white;
	color:navy;
	font-size:12pt;
	font-weight:bold;
}


</style>
    <script>window.status='ORA Production Database';</script>
</head>
<body>
    <form action method="POST" id="form1" name="form1">
        <!-- Outer Table -->
        <table width="650" cellpadding="2" cellspacting="0" border="1">
            <tr>
                <td class="GlobalTd">
                    <script>window.status='ORA Production Database';</script><table width="100%" cellpadding="0" cellspacing="0" border="0px">
<tr>
<td>Protocol#: B-20170011<br><br><div class="hdg1" align="center">University of California, Riverside<br>Institutional Biosafety Committee (IBC)<br>Application for Biological Use Authorization Registration</div>
<br><div class="hdg2">A. INVESTIGATOR DATA</div>
<table border="0" cellpadding="1" cellspacing="1" width="100%">
<tr>   <th class="THBlue">Principal Investigator</th>   <td class="TDBlue">Ernest  Martinez</td>
<td rowspan="10">&#160;&#160;&#160;&#160;&#160;</td>   <th class="THBlue">Email</th>   <td class="TDBlue">ernest.martinez@ucr.edu</td>
</tr>
<tr>   <th class="THBlue">Department</th>   <td class="TDBlue">Biochemistry</td>   <th class="THBlue">Phone</th>   <td class="TDBlue">(951)827-2031</td>
</tr>
<tr>   <th class="THBlue">Project Start/End Date</th>   <td class="TDBlue">9/1/2005-8/31/2020</td>   <th class="THBlue">Fax</th>   <td class="TDBlue">(951) 827-4434</td>
</tr>
<tr>   <th class="THBlue" colspan="5">
<br>Project Title:</th>
</tr>
<tr>   <td class="TDBlue" colspan="5">Gene regulation by oncoproteins, chromatin coregulators and lncRNAs
</td>
</tr>
<tr>   <th class="THBlue" colspan="5">
<br>Related Funding Agency(ies) (add as many as apply, even if use of rDNA is identical for each project):</th>
</tr>
<tr>   <td class="TDBlue" colspan="5">NIH, NSF, UCCRCC</td>
</tr>
<tr><td colspan="5">&#160;</td></tr>
<tr>   <th class="THBlue" colspan="2">Additional Contact person and phone # (if not or in addition to the PI):</th>   <td class="TDBlue" colspan="2">Lab phone 2-2046</td>
</tr>
</table>
<br><br><div class="hdg2">B. RESEARCH LOCATIONS</div>
<table border="1" width="100%" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue" width="15%">Building &#160;&#160;&#160;</th>   <th class="THBlue" width="15%">Room #  &#160;&#160;&#160;</th>   <th class="THBlue" width="55%">List any containment facilities or equipment (biosafety cabinets, etc.) and their last certification dates. &#160;&#160;&#160;</th>   <th class="THBlue" width="15%">Certification<br>Date</th>
</tr>
<tr>   <td class="TDBlue">Boyce Hall&#160;&#160;&#160;</td>   <td class="TDBlue">4481&#160;&#160;&#160;</td>   <td class="TDBlue">Fume hood, Chemicals&#160;&#160;&#160;</td>   <td class="TDBlue">2/21/2014&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Boyce Hall&#160;&#160;&#160;</td>   <td class="TDBlue">4447&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Boyce Hall&#160;&#160;&#160;</td>   <td class="TDBlue">4413&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Boyce Hall&#160;&#160;&#160;</td>   <td class="TDBlue">4451&#160;&#160;&#160;</td>   <td class="TDBlue">Fume hood - Chemicals&#160;&#160;&#160;</td>   <td class="TDBlue">2/21/2014&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Boyce Hall&#160;&#160;&#160;</td>   <td class="TDBlue">4471&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Boyce Hall&#160;&#160;&#160;</td>   <td class="TDBlue">4467&#160;&#160;&#160;</td>   <td class="TDBlue">Fume hood - radioactive waste&#160;&#160;&#160;</td>   <td class="TDBlue">2/21/2014&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Boyce Hall&#160;&#160;&#160;</td>   <td class="TDBlue">4461&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Boyce Hall&#160;&#160;&#160;</td>   <td class="TDBlue">4477&#160;&#160;&#160;</td>   <td class="TDBlue">Biosafety Cabinets - Cell culture&#160;&#160;&#160;</td>   <td class="TDBlue">3/7/2017&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Boyce Hall&#160;&#160;&#160;</td>   <td class="TDBlue">4457&#160;&#160;&#160;</td>   <td class="TDBlue">Biosafety Cabinet - Cell culture&#160;&#160;&#160;</td>   <td class="TDBlue">3/7/2017&#160;&#160;&#160;</td>
</tr>
</table>
<br><br><div class="hdg2">C. PRIOR APPROVAL STATUS</div>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Application Type</th>   <td width="50%" class="TDBlue">Renewal</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, please list the number of the approved protocol</th>   <td class="TDBlue">20140015</td>
</tr>
<tr>   <th class="THBlue">Does this project involve human or animal subjects, or a positive disclosure of a conflict of interest (income, loans, or management role in funding source, etc.)?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, has this project been reviewed by any other UCR review boards?  If so, indicate the relevant protocol numbers and approval dates:</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">IRB (human subjects)</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">IACUC (animal subjects)</th>   <td class="TDBlue">A-20140036</td>
</tr>
<tr>   <th class="THBlue">Conflict of interest (provide approval date)</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Does this project involve strains of plant or animal pathogens not originating in California?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, CDFA and APHIS permits may be required.  List the relevant permit numbers and dates covered:</th>
</tr>
<tr>   <th class="THBlue">CDFA</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">APHIS</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Do experiments involve releasing organisms containing rDNA into the environment?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, has an application for this release been filed with a state or federal regulatory agency?	Agency and date filed:</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Will you be using  a "Select Agent" (<a href="http://www.cdc.gov/od/ohs/lrsat.htm">www.cdc.gov/od/ohs/lrsat.htm</a>)</th>   <td class="TDBlue">False</td>
</tr>
</table>
<br><br><div class="hdg2">DESCRIPTION OF PROJECT</div>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue">Provide a brief, non-technical description and purpose of the project.</th>
</tr>
<tr>   <td class="TDBlue">Study of transcription factors, chormatin-modifying cofactors, long non-coding RNAs, and cognate mechanisms involved in regulation of chromatin and transcription of specific genes during cell proliferation and differentiation and in cancer cells using in vitro systems, cultured mammalian cells, and mouse models. Procedures include purification of mammalian protein cofactors and chromatin components to reconstitute transcription regulation in vitro and creation of mammalian cell lines to purify transcription coactivator complexes. Culture and transfection of mammalian cells with promoter/reporter vectors, cDNA and RNAi expression vectors, and gene editing vectors (such as CRISPR/Cas system) to study gene regulation in vivo. Overexpression of Myc and associated cofactors in human cells with recombinant replication-deficient viruses.</td>
</tr>
<tr>   <th class="THBlue">What are the specific objectives of the work with biohazardous materials?</th>
</tr>
<tr>   <td class="TDBlue">1. To generate and amplify plasmid DNA in E. coli.
2. To express recombinant transcription factors in E. coli.
3. To express recombinant proteins using baculovirus systems.
4. To express recombinant proteins, siRNAs, lncRNAs in cultured mammalian cells (Hela, HL-60, 293, COS-7, IMR90 and others) using transient and stable transfection with expression vectors and/or by transduction with replication-defective Adenoviral or retroviral/lentiviral particles.
5. To analyze the tumorigenicity of genetically-modified  cancer cell lines indue mice.
6. To generate mouse models modified in their expression of lncRNAs or MYC oncoprotein and analyze roles of this factors during development and in cancer.</td>
</tr>
</table>
<br><br><div class="hdg2">Potentially Biohazadous Materials</div>Please indicate yes or no if the following biohazardous materials are used currently within your laboratory or are proposed with the next year.  Please check all that apply.<table width="100%" border="0" cellpadding="0" cellspacing="0">
<tr>   <th colspan="2"><span class="hdg3">Human or Animal Infectious Agents</span></th>
</tr>
<tr>   <th class="THLine1">Viruses</th>   <td class="TDLine1">True</td>
</tr>
<tr>   <th class="THLine2">Bacteria</th>   <td class="TDLine2">True</td>
</tr>
<tr>   <th class="THLine1">Fungi</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Prions</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Plant Infectious Agents</span>
</th>
</tr>
<tr>   <th class="THLine1">Viruses</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Bacteria</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Fungi</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Other</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Recombinant DNA</span>
</th>
</tr>
<tr>   <th class="THLine1">Recombinant DNA in any form.</th>   <td class="TDLine1">True</td>
</tr>
<tr>   <th class="THLine2">Intentional release to the environment</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Transgenic Plants</span>
</th>
</tr>
<tr>   <th class="THLine1">Plants</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Liverworts</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Mosses</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Algae</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Animals</span>
</th>
</tr>
<tr>   <th class="THLine1">Animals that are potential reservoirs of zoonotic diseases<br>(primates, wild animals, etc.)</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Infectious or hazardous agents in animals</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Human or primate cells in animals</th>   <td class="TDLine1">True</td>
</tr>
<tr>   <th class="THLine2">Transgenic animals</th>   <td class="TDLine2">True</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Invertebrates</span>
</th>
</tr>
<tr>   <th class="THLine1">Exotic Arthropods</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Nematodes</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Intentional release to the environment</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Transgenic Insects</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Human Stem Cells</span>
</th>
</tr>
<tr>   <th class="THLine1">Human Stem Cells</th>   <td class="TDLine1">True</td>
</tr>
</table>
<br><div class="hdg2">Human or Animal Infectious Agents</div>
<table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">List of Agents &#160;&#160;&#160;</th>   <th class="THBlue">Host of Range of Agent &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">lentivirus (replication deficient)&#160;&#160;&#160;</td>   <td class="TDBlue">human &amp; rodents&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">retrovirus (replication-deficient)&#160;&#160;&#160;</td>   <td class="TDBlue">human &amp; rodents&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Adenovirus (replication-deficient)&#160;&#160;&#160;</td>   <td class="TDBlue">Human/primate&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Human Cell lines: HEK293, HeLa, MCF7, PC3, U2OS, SAOS2,HL60, HCT116, DLD1, HEPG2, IMR90, WI38, HK2, Caki-1, ACHN&#160;&#160;&#160;</td>   <td class="TDBlue">Human&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Human Embryonic Stem cell line H1 (W01)&#160;&#160;&#160;</td>   <td class="TDBlue">Human&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Rat cell line: Rat1a fibroblast&#160;&#160;&#160;</td>   <td class="TDBlue">Rodent&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Mouse ES cell lines: D3, KH2&#160;&#160;&#160;</td>   <td class="TDBlue">Rodent&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Monkey COS-7 cell line&#160;&#160;&#160;</td>   <td class="TDBlue">Primate&#160;&#160;&#160;</td>
</tr>
</table>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Are you using the wild-type of the agent?</th>   <td width="50%" class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Are you using genetically modified infectious agents (rDNA, mutagenesis, etc.)?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; please describe the agent and any potential safety issues.</th>   <td class="TDBlue">We will use adenoviral or retroviral or lentiviral vectors expressing Myc, siRNAs or other transcription factors. The recombinant viral particles  will not replicate in cells other than complementing cells (293 cells or others) and adenoviruses are generally considered of minimal potential harm (Biosafety level II).  Nevertheless, because of the oncogenic properties of Myc, we will minimize the risk of contamination by the following strict safety measures described further below.</td>
</tr>
<tr>   <th class="THBlue">Do the experiments have the potential to increase the host range of the agent?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Is the vector replication competent?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Are you using fusion proteins or cell entry domains?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; please describe any safety precautions you would recommend.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Are you using human or primate blood, blood products, cells, cell lines or tissues</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#147;yes,&#148; please describe the blood, blood products, cells, cell lines or tissue and detail how the sample will be worked with during experimentation. Please include vendor information such as the ATCC number if available.</th>   <td class="TDBlue">We will use the common human cell lines: HeLa (cervical cancer), PC3 (prostate cancer), U2OS and SAOS2 (osteosarcoma), HL60 (promyelocytic leukemia), Namalwa (Burkitt's Lymphoma) , HCT116 and DLD1 (colorectal carcinoma), MCF-7 (breast cancer), HepG2(liver hepatoma), HEK293 (E1a-transformed human embryonic kidney cells), IMR90 and WI38 (human fibroblasts) and other established mammalian cell lines), and the monkey COS-7 cell line. These are available from a variety of commercial sources (including ATCC). We will also use  human ES cells (H1) and mouse ES cells (D3, KH2) in vitro and in subcutaneous teratoma assays in nude mice.</td>
</tr>
</table>
<br><div class="hdg2">Recombinant DNA</div>
<table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">General features of the DNA &#160;&#160;&#160;</th>   <th class="THBlue">Species from which DNA originated &#160;&#160;&#160;</th>   <th class="THBlue">Species to receive DNA, type of vector, and transformation method &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">Myc cDNA (and other transcription factors of no known pathonegic activity)&#160;&#160;&#160;</td>   <td class="TDBlue">human and mouse&#160;&#160;&#160;</td>   <td class="TDBlue">E. coli (inducible T7 bacterial expression vectors), Insect Sf9/Sf21 cells (baculovirus expression vectors), human cell lines and other mammalian cell lines (CMV promoter-based plasmid expression vect&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">DNA oligonucleotides encoding small interfering RNAs (siRNAs) directed against human/mouse/monkey mRNAs encoding Myc and other transcription factors.&#160;&#160;&#160;</td>   <td class="TDBlue">synthetic&#160;&#160;&#160;</td>   <td class="TDBlue">Cultured human and other mammalian cell lines (HeLa, HL60, 293, IMR90, COS-7) will be transfected with liposomes or transduced with replication-defective adenoviral particles.&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Expression vectors for cDNAs  encoding MYC and other transcription regulatory proteins.&#160;&#160;&#160;</td>   <td class="TDBlue">Human or rodent&#160;&#160;&#160;</td>   <td class="TDBlue">Common cultured mammalian cell lines including human cell lines (listed in previous sections), liposome transfection or transduction with replication-defective adenoviral or retroviral/lentiviral part&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">long non-coding RNAs&#160;&#160;&#160;</td>   <td class="TDBlue">human and mouse&#160;&#160;&#160;</td>   <td class="TDBlue">Transfection of  mammalian cells in culture, transformation of E.coli&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">CRISPR/CAS expression vectors for guide RNAs and Cas9 nuclease&#160;&#160;&#160;</td>   <td class="TDBlue">Bacterial&#160;&#160;&#160;</td>   <td class="TDBlue">mammalian cells (including mouse and human cell lines) described in materials section.&#160;&#160;&#160;</td>
</tr>
</table>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Will cultures of any recombinant organisms listed above exceed a volume of 10 liters?  </th>   <td width="50%" class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If so, where will the cultures be grown?</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Does your experiment involve the transfer of a drug resistance trait to any microorganism, plant, or insect that does not acquire that trait naturally?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe any potential environmental or health hazards of the experiments, including whether acquiring such a trait would compromise the use of the drug in medicine or agriculture.</th>   <td class="TDBlue">NO health or enviromnental hazard. Cultures will be bleached and plastics/materials autoclaved before disposal. Commonly used drug-selection methods for E. coli transformants (Ampicillin) and for stable generation of mammalin cell lines (neomycin, hygromycin, puromycin).</td>
</tr>
<tr>   <th class="THBlue">Are you expressing genes encoding toxins with LD 50 less that 10 ng/kg of body weight?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the toxic product and safety precautions.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Are you using hosts or vectors of rDNA (excluding E. coli K-12) that are viable pathogens of animals, plants, or microbes?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe any potential environmental or health hazards, containment precautions, and disposal protocols.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Are you using recombinant DNA molecules containing the partial genome of any eukaryotic (plant or animal) virus?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the molecules, including genetic maps and the fraction of virus genome present, and safety precautions.</th>   <td class="TDBlue">We will use replication-defective retroviral/lentiviral vectors or adenoviral vectors that lack the E1/E3 regions and therefore cannot replicate in cells other than complementing cells (293 cells). 

We will minimize the risk of contamination by the following: (i) working in class IIA/B3 laminar flow biosafety cabinets. (ii) No food or drinks are allowed in our BSL2 laboratory and access is restricted by a key-locked door. (iii) Gloves, goggles, mask, and lab coats will be worn. (iv) in the event of a spill the surface wil be decontaminated with 10% bleach (sodium hypochlorite) for at least 30 min. (v) Solid and liquid waste will be decontaminated by autoclaving in double red/biological bags. (vi) personnel will be instructed about the risks and symptoms of adenoviral infection. To avoid the emergence of E1-containing Ad, we will 1- always plaque purify the adenoviral stocks to be amplified, and 2- keep the passage number in 293 cells as low as possible.</td>
</tr>
<tr>   <th class="THBlue">Are your experiments likely to enhance the pathogenicity or extend the host range of a viral vector (e.g., introduction of novel control elements or a oncogene)?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the hazards and safety precautions.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Will you be using genes involved in cell cycle control in animals (oncogene, tumor suppressor, cytokine, etc.)?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the potential hazards.</th>   <td class="TDBlue">Myc is an oncogene. For transient expression using viral vectors, we will minimize the risk of contamination by the  safety measures described above. Note that although Myc is an oncogene it cannot by itself transform human cells but requires secondary mutations in cooperating oncogenes and tumor suppressor genes. Furthermore the adenovirus genome does not integrate into the host genomic DNA and thus is not replicated in dividing cells. Thus the risks to human health are considered low in case of accidental injection or contact with mucosae. After accidental injection the area will be washed extensively with soap and water and EH&amp;S will be contacted immediately.</td>
</tr>
<tr>   <th class="THBlue">Medical surveillance requirements or practices that you would recommend (antibody titering, etc.)?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, list your recommendations in section 5.</th>   <td class="TDBlue"></td>
</tr>
</table>
<br><div class="hdg2">Vertebrates</div>
<table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">Animal &#160;&#160;&#160;</th>   <th class="THBlue">Infectious Agent &#160;&#160;&#160;</th>   <th class="THBlue">Route(s) of Shedding/Excretion of Infectious Agents &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">Mice&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
</table>
<table border="0" width="100%" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Are you using human or primate cells in animals?</th>   <td width="50%" class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">Are you infecting animals with infectious agents?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; describe any potential environmental or health hazards, containment precautions, and disposal protocols.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Do the animals shed the infectious agents?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; how long will shedding of the infectious agent occur?</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Are you using animals that have been caught in the wild?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Are there potential zoonotic diseases associated with the animals?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; describe any potential environmental or health hazards, containment precautions, and disposal protocols.</th>   <td class="TDBlue">Laboratory mice are bred to exclude all zoonotic agents.  Therefore, unless the laboratory mice are exposed to wild mice (those coming from the natural habitat outside the laboratory), there is limited concern for disease from these research mice.  </td>
</tr>
</table>
<br><div class="hdg2">Human Stem Cells</div>
<b>Complete the following for each line obtained from a source outside of UCR.</b><table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">Line &#160;&#160;&#160;</th>   <th class="THBlue">Cell Type &#160;&#160;&#160;</th>   <th class="THBlue">NIH Registry &#160;&#160;&#160;</th>   <th class="THBlue">Institution/Company &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">H1 (WA01) &#160;&#160;&#160;</td>   <td class="TDBlue">Embryonic stem cell line&#160;&#160;&#160;</td>   <td class="TDBlue">0043 (NIHhESC-10-0043)&#160;&#160;&#160;</td>   <td class="TDBlue">WiCell Research Institute&#160;&#160;&#160;</td>
</tr>
</table>
<br><b>Complete the following for each line developed at UCR.</b><table width="100%" border="1" cellpadding="1" cellspacing="0"></table>
<table border="0" width="100%" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue" colspan="2">For all stem cell lines, describe procedures that will be carried out to ensure safety (i.e. special handling conditions, tests for microbiological sterility, etc.).</th>
</tr>
<tr>   <td class="TDBlue" colspan="2">All personnel will be trained (Biosafety/Bloodborne pathogen training) and wearing PPE (lab coat, safety glasses, gloves). Work will be performed in a BSL2 lab (Boyce hall 4413) and in a biosafety cabinet that will be disinfected before and after each use. Cell cultures will be maintained in HEPA-filtered CO2 incubators. Cultures will be routinely tested for mycoplasma contamination. All cell culture media will be decontaminated with 10% bleach and plastics will be autoclaved in red biohazard bags before disposal. After exiting the cell culture room lab coats will be changed and hands washed. Tainted lab coats will be disposed in bags in laundry hampers and professionally cleaned.</td>
</tr>
</table>
<br><br><div class="hdg2">Define Controls</div>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue" width="50%">Do you need special equipment, engineering safeguards or personal protective equipment to maintain containment of your experiments (hoods, negative pressure rooms, gloves, etc.) </th>   <td class="TDBlue" width="50%">True</td>
</tr>
<tr>   <th class="THBlue"> If &#8220;yes&#8221;, list your recommendations.</th>   <td class="TDBlue">Biosafety cabinet/hood type A2 (former IIA/B3)
Typical personal protective equipment: lab coat, gloves, goggles</td>
</tr>
<tr>   <th class="THBlue">Medical surveillance requirements or practices that you would recommend (antibody titering, etc.)? </th>   <td class="TDBlue">none.
Hepatitis B vaccination recommended (or waiver requested).</td>
</tr>
<tr>   <th class="THBlue">Suggested level of biological containment.</th>   <td class="TDBlue">BSL2</td>
</tr>
</table>
<br><div class="hdg2">Acknowledgement of Responsibilities</div>
<div class="tdBlue">For each of the elements below, please indicate if you will be following the UCR standard operating procedures and/or policies. If you indicate &#8220;yes&#8221; then you agree to and must follow the standard procedures and/or policies. If you answer &#8220;no,&#8221; please enter a brief description (in the space provided below the question) of the procedure you will follow and include a justification for deviating from the standard procedure and/or policy.</div>
<table border="0" width="100%" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue">Decontamination of biohazardous spills: I will used a 0.5 % sodium hypochlorite  (1:10 dilution of household bleach) to decontaminate equipment and work surfaces.  In locations where bleach would cause corrosion, I will decontaminate with an iodophor (e.g., Wescodyne).</th>   <td class="TDBlue" nowrap>True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Storage: Biohazardous material will be clearly labeled with the universal biohazard symbol.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">If I am using human or non-human primate blood or blood products, unfixed tissue, bodily fluids or organ or cell cultures of human origin, I will follow the exposure control plan for bloodborne pathogens.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">All injuries and accidental inoculation, ingestion or inhalation of biohazardous material will be reported immediately to the lab director or supervisor and EH&amp;S (827-2648).  Dial 911 immediately for any medical emergency.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">All shipments of biological materials will follow university policy and all applicable federal and international regulations whenever shipped domestically or internationally.  Proper importation or exportation permits and licenses will be obtained before shipping or reviving biological materials to or from any international location.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">If I am generating medical and/or biohazardous waste, I will abide by the UC Riverside Medical and/or Biological waste plans.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">I understand that UC Riverside may be required by law to release a copy of this application to the public.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">I understand that failure to comply with the applicable regulations governing the use of biohazardous materials described above may result in suspension of the authorization and might jeopardize any funding supporting the activities described herein.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">I attest that I will conduct the study identified above in the manner described.  If I decide to make any changes in the procedure or if any problems occur which involve risk or the possibility of risk to others, I will immediately report such occurances or contemplated changes to the UCR Institutional Biosafety Committee, Research and Economic Development, 200 University Office Building, ext 2-4809; IBC@ucr.edu.</th>   <td class="TDBlue">True</td>
</tr>
</table>
<br><table border="0" width="100%" cellpadding="0" cellspacing="0">
<tr>
<td>______________________________</td>
<td>___________</td>
<td rowspan="2">&#160;&#160;&#160;&#160;</td>
<td>______________________________</td>
<td>___________</td>
</tr>
<tr>
<td>Principal Investigator</td>
<td>Date</td>
<td>Co-Investigator</td>
<td>Date</td>
</tr>
</table>
<br><em>Electronically signed and submitted to ORA on 4/5/2017 11:02:03 AM by <b>Ernest Martinez</b></em><hr>IBC CERTIFICATION<div class="tdBlue">I certify that the Institutional Biosafety Committee has reviewed the proposed project.  In compliance with NIH guidelines and other specific NIH instructions, the project is (check one)<br><img src="/appAsp/images/CheckBox.gif"> Approved as is.<br><img src="/appAsp/images/CheckBox.gif"> Approved with the following conditions:<br><br><br>
</div>
<table border="0" width="100%" cellpadding="0" cellspacing="0">
<tr>
<td>Level:	<img src="/appAsp/images/CheckBox.gif">BL1 &#160;&#160;<img src="/appAsp/images/CheckedBox.gif">BL2 &#160;&#160;<img src="/appAsp/images/CheckBox.gif">BL3 &#160;&#160;<img src="/appAsp/images/CheckBox.gif">BL4 &#160;&#160;</td>
<td>
<em>Electronically Signed by<br><u><b>Djurdjica Coss</b></u></em> __________________________4/28/2017</td>
</tr>
<tr>
<td>&#160;</td>
<td>Chair-Institutional Biosafety Committee &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Date</td>
</tr>
</table>
                    <!-- End Outer Table -->
                </td>
            </tr>
        </table>
    
</td>
</tr>
</table>
</form>
</body>
</html>
